FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
502 letters match. Newest first.
-
DrugsHello Cake, Inc. dba Hello Cake
FDA warns Hello Cake, an online telehealth seller, that its website misbrands compounded sildenafil and tadalafil ED drugs as equivalent to Viagra and Cialis.
Medium -
DrugsSprout Health Partners LLC dba Sprout Health
FDA warned telehealth seller Sprout Health that its website's claim compounded semaglutide and tirzepatide are FDA-approved makes the drugs misbranded.
Low -
DrugsMaster Pharmaceuticals Group
FDA warned Master Pharmaceuticals Group that its website sold compounded semaglutide and tirzepatide with false or misleading claims.
High risk -
DrugsTRYM Health, Inc. dba TRYM Health
FDA told telehealth seller TRYM Health its website claims for compounded semaglutide and tirzepatide are false and misleading, making the drugs misbranded.
Medium -
Drugsinspire.clinic
FDA warned telehealth site inspire.clinic that claims its compounded semaglutide and tirzepatide are similar to Ozempic or Mounjaro misbrand the drugs.
Low -
DrugsBioverse, Inc. dba Bioverse
FDA warned Bioverse that its website made false or misleading claims for compounded semaglutide and tirzepatide drugs.
Low -
DrugsEvoLife Wellness
FDA warned EvoLife Wellness that its website wrongly calls compounded semaglutide and tirzepatide "FDA-Approved," making the drugs misbranded.
Medium -
DrugseDrugstore
FDA warns eDrugstore over claims that compounded tirzepatide is FDA-approved, making drugs misbranded (falsely promoted).
High risk -
DrugsMedClub by Dr. Jenn
FDA warns MedClub by Dr. Jenn over unapproved compounded retatrutide and misleading semaglutide claims on its website.
High risk -
DrugsGLP-1 Solution
GLP-1 Solution sells unapproved compounded retatrutide online and misleadingly compares semaglutide and tirzepatide to FDA-approved brand drugs.
High risk -
DrugsASN-LABS
ASN-LABS marketed unapproved compounded retatrutide and misleading semaglutide claims online, FDA says.
High risk -
DrugsRemedy Meds
FDA warns Remedy Meds that its telehealth site misleadingly labels pharmacy-made semaglutide and tirzepatide with approved-drug comparisons.
Low -
DrugsEA WORKS Limited Liability Company dba Trust Labs
FDA warned Trust Labs it sold unapproved compounded retatrutide and made false FDA-approval claims for semaglutide and tirzepatide online.
High risk -
DrugsFancy Meds, LLC dba Fancy Meds
FDA warns Fancy Meds that its compounded semaglutide and tirzepatide website claims are false or misleading.
Low -
DrugsCurex
FDA warned Curex that its website ads for compounded semaglutide and tirzepatide are false or misleading.
High risk -
BiologicsCSL Behring
FDA says CSL Behring's HIZENTRA TV ad overstates protection and plays down risks, misbranding the immune globulin biologic.
Medium -
BiologicsNuVida Medical LLC
FDA says NuVida Medical sells unapproved, unlicensed tissue products for non-homologous wound care uses.
High risk -
DevicesSeniorLife Technologies, Inc.
FDA warns SeniorLife Technologies that its SeniorLife.AI app is unapproved and misbranded, with quality-system and reporting failures.
High risk -
FoodMericon Industries, Inc.
Mericon Industries sold Florical and Meribin supplements with unapproved drug claims for osteoporosis and serious manufacturing and labeling failures.
High risk -
DrugsMy Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD
FDA warned My Holistic Honey that its honey eye drops are an unapproved new drug sold with drug claims.
High risk -
DrugsHomeopathic Educational Services dba Homeopathic Family Medicine
FDA says Homeopathic Family Medicine sells unapproved Cineraria Maritima Eye Drops for cataracts online.
High risk -
DrugsSupply Center USA
Supply Center USA offered unapproved Similasan and Boiron eye drug products for sale online.
High risk -
DrugsTrew Balance
FDA warned Trew Balance that its Trew Vision CBD Eye Drops are an unapproved new drug sold with disease-treatment claims.
High risk -
AnimalSynergy Animal Products, Inc.
Synergy Animal Products marketed unapproved animal drugs for dairy cows with inadequate directions and major manufacturing violations.
High risk -
DrugsAlzClipp / UniUni
FDA warns AlzClipp/UniUni that its AlzClipp nasal product is an unapproved new drug and misbranded with false FDA approval claims.
High risk -
AnimalMeds For Vets, LLC
Meds For Vets compounded unapproved animal drugs from bulk substances and failed manufacturing quality rules, including sterility controls.
High risk -
Drugswww.usaquickmeds.com
FDA warned usaquickmeds.com for selling unapproved and misbranded opioids and benzodiazepines online without prescriptions.
High risk -
DrugsVacation Inc.
FDA warned Vacation Inc. that its whipped-cream-style sunscreen mousses are unapproved drugs and that their food-like cans are misleading.
High risk -
DrugsKalani AB dba Kalani Sunwear
FDA warns Kalani AB that its Sun Mousse SPF 50 sunscreen is an unapproved, misbranded drug for US sale.
High risk -
DrugsK & Care Organics
FDA warns K & Care Organics over unapproved over-the-counter (OTC) foam sunscreen drugs sold in the U.S. without required authorization.
High risk -
DrugsFallien Cosmeceuticals Ltd. dba Fallene Ltd.
FDA warns Fallien over unapproved OTC sunscreen foam TiZO SHEERFOAM SPF 30 sold without required authorization.
Medium -
DrugsSupergoop!
FDA warned Supergoop! that its over-the-counter sunscreen body mousse is illegally labeled because foam dosage forms are not allowed under the sunscreen monograph.
Medium -
DrugsConfer With
FDA told London-based Confer With that its Vivant True Tone skin-lightening serum is an unapproved drug sold without FDA approval.
High risk -
DevicesMectronic Medicale S.R.L.
FDA warns Mectronic Medicale over quality system failures and uncleared marketing of therapeutic RF/laser devices.
High risk -
DevicesOnkos Surgical, Inc.
FDA warns Onkos Surgical over ELEOS implant system cleaning, corrective-action, risk, sampling, and removal-reporting failures.
High risk -
Drugswww.mysteroidsmarket.com
FDA warns Israel-based website mysteroidsmarket.com for selling unapproved and misbranded stimulants and benzodiazepines to U.S. consumers.
High risk -
Drugswww.d-pharmacy.com
FDA warned Singapore website d-pharmacy.com for selling unapproved prescription opioids, benzodiazepines, and stimulants to U.S. consumers.
High risk -
Drugswww.portmeds.com
FDA warned www.portmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants online without prescriptions.
High risk -
Drugswww.plakini-pharma.com
FDA warned Malaysia-based website plakini-pharma.com for selling unapproved, misbranded opioids, benzodiazepines, and stimulants to U.S. consumers.
High risk -
DrugsCovalent Medical
FDA warned Covalent Medical that its FOCUS PI post-injection eye drops are an unapproved new drug with claims not allowed for over-the-counter eye products.
Medium -
DrugsScope Health Inc
FDA says Scope Health sold unapproved OTC eye drugs online and misbranded several products.
High risk -
DrugsRevitalize Energy, Inc.
FDA warned Revitalize Energy that its Revitalize Energizing Eye Drops are an unapproved new drug and misbranded.
High risk -
DrugsThea Pharma, Inc.
FDA warns Thea Pharma that IVIZIA OTC lubricant eye drops are an unapproved and misbranded new drug.
High risk -
DrugsEyeTech One, LLC
FDA warns EyeTech One that its EYELIVIO lubricant eye ointment is an unapproved new drug and misbranded.
Medium -
FoodRoyal Diamond Imports, Inc.
FDA warned Royal Diamond Imports that its Roxy 7-OH kratom tablets are unapproved new drugs and its kratom drink mix contains an unsafe food additive.
High risk -
FoodRelax Relief Rejuvenate Trading, LLC dba RRR Trading or EDP Kratom
FDA says RRR Trading's EDP 7OH kratom extract shot is an adulterated supplement; its 7-OH ingredient lacks safety evidence.
High risk -
FoodMy Smoke Wholesale
My Smoke Wholesale's 777 Jackpot Alkaloids tablets are adulterated dietary supplements because 7-OH lacks adequate safety information.
High risk -
AnimalJ.D. Heiskell Holdings LLC
J.D. Heiskell's Idaho feed mill made calf feed with too much monensin linked to calf deaths, then mixed the recalled feed into non-medicated feed.
High risk -
DevicesInsightra Medical Inc.
FDA warns Insightra Medical over unapproved IABP catheter claims and missed adverse-event reports.
High risk -
BiologicsInVia Fertility Specialists, PLLC
FDA warned InVia Fertility Specialists over reproductive tissue donor eligibility and missing infectious disease testing.
High risk